Navigation Links
Janina A. Longtine, MD of the Icahn School of Medicine at Mount Sinai Elected President of the Association for Molecular Pathology
Date:9/4/2013

New York, NY (PRWEB) September 04, 2013

Janina A. Longtine, MD, has been elected President of the Association for Molecular Pathology (AMP), an international medical professional association dedicated to advancing the clinical practice, science and excellence of molecular and genomic laboratory medicine through education, innovation and advocacy to enable highest quality health care.

Dr. Longtine’s election results in a three-year term on the Board of Directors and Executive Committee; the first year serving as President-Elect and Chair of the Strategic Planning Committee (2013-2014), the second as President (2014-2015), and the third as Past-President and Chair of the Nominating Committee (2014-2015). The turnover occurs at the society’s annual meeting, which is held in November.

“In this era of genomic medicine, the field of molecular pathology is rapidly changing, and we must bring new knowledge and technologies to both the clinical and translational research settings, transforming our understanding, classification and treatment of disease,” said Dr. Longtine, who is Vice-Chair of Molecular Pathology and Genetics in the Department of Pathology at the Icahn School of Medicine at Mount Sinai. “The Association for Molecular Pathology is at the forefront in guiding its members and the broader community through clinical implementation, economic, and regulatory challenges via advocacy, education, and evidence-based guidelines for innovative practices that improve patient care and outcomes. I am proud to lead AMP in these endeavors.”

Molecular pathologists study the origins and pathogenesis of disease based on the characterization of inherited or acquired genetic mutations and alterations of gene products and translates them into clinical tests that provide more precise information for each patient’s care. Mount Sinai’s Division of Molecular Pathology and Genetics is particularly focused on cancer, with physicians and scientists performing an expanding array of biomarker tests that stratify cancers into biologic subgroups for rational, personalized therapy using advanced technologies.

The Department of Pathology is chaired by Carlos Cordon-Cardo, MD, PhD, who is a distinguished physician-scientist recognized internationally for his groundbreaking research in experimental pathology and molecular oncology. Dr. Cordon-Cardo has outlined a broad vision that redefines the discipline of Pathology, placing it at the core of patient management and individualized medicine.

”Dr. Longtine’s election as the President of the AMP is a strong endorsement of her expertise and leadership in molecular pathology, a cutting-edge discipline that is key to the future of pathology, especially as we move into value-based medicine,” said Dr. Cordon-Cardo. “I am most proud that Dr. Longtine is part of our leadership team as Vice Chair of Molecular Pathology and Genetics, is helping transform the practice of pathology at The Mount Sinai Medical Center, and is training our next generation of pathologists.”

Prior to joining Mount Sinai in 2011, Dr. Longtine spent her career at the Brigham and Women’s Hospital and Dana-Farber Cancer Institute in Boston, where she was most recently Director of Molecular Diagnostics and Co-Director of the Center for Advanced Molecular Diagnostics in the Department of Pathology, Program Director of the Harvard Medical School Molecular Genetic Pathology Fellowship and an Associate Professor of Pathology at Harvard Medical School. Previously, Dr. Longtine has served as the Chair of the Clinical Practice Committee and Chair of the Hematopathology Division of the Association for Molecular Pathology.

About The Mount Sinai Medical Center
The Mount Sinai Medical Center encompasses both The Mount Sinai Hospital and Icahn School of Medicine at Mount Sinai. Established in 1968, the Icahn School of Medicine is one of the leading medical schools in the United States, with more than 3,400 faculty in 32 departments and 14 research institutes. It ranks among the top 20 medical schools both in National Institutes of Health (NIH) funding and by U.S. News & World Report. The Mount Sinai Hospital, founded in 1852, is a 1,171-bed tertiary- and quaternary-care teaching facility and one of the nation’s oldest, largest and most-respected voluntary hospitals. In 2012, U.S. News & World Report ranked The Mount Sinai Hospital 14th on its elite Honor Roll of the nation’s top hospitals based on reputation, safety, and other patient-care factors.

For more information, visit http://www.mountsinai.org.

Find Mount Sinai on:
Facebook: http://www.facebook.com/mountsinainyc
Twitter: @mountsinainyc

# # #

Read the full story at http://www.prweb.com/releases/2013/9/prweb11090871.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. World-Renowned Gastroenterologist Jean-Frédéric Colombel, MD, Joins the Icahn School of Medicine at Mount Sinai
2. Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles
3. Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration
4. Icahn School of Medicine at Mount Sinai and Bene Pharmachem Gmbh to Collaborate on Clinical Studies for Mucopolysaccaridoses
5. Icahn School of Medicine at Mount Sinai Honors Innovators in Scientific Research and Health Care Philanthropy at 2013 Commencement Ceremony
6. The 5 Worst Problems Left-Handers Face at School: Thelefthandstore.com Asked Its Customers, Facebook Friends, and Staff
7. Creating Compassionate Schools and Communities; Those Out On the Front-lines Working With Youth to Stop Bullying Are Meeting in Nashville to Make a Difference
8. A Premiere Career Training Certificate School, CSI, Now Accepting Back to Community Scholarship Applications for Qualifying Students
9. The Otter Way Launches as Children Head Back to School
10. Carol Fenster’s Back-to-School Tips for Gluten-Free Meals
11. Dr. Ran Rubinstein Offers Back to School Special with Isolaz and Clear & Brilliant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... Park, KS (PRWEB) , ... February 08, 2016 , ... ... a leader in Mole removal products. , Moles are derived from a cluster of ... appear in all the wrong places and create a lifetime of embarrassment. Historically, ...
(Date:2/8/2016)... ... , ... Guruji Mahendra Kumar Trivedi is offering 3 days of accelerated personal ... birthday on February 10th. During this time, people can achieve better health, greater ... people from over 40 different countries as an “ordinary man with an extraordinary gift.” ...
(Date:2/8/2016)... ... ... According to research by the National Association of Dental ... certified or obtain continuing education. To increase patient awareness of the lack of ... to inform dentists and patients about the possible lack of skills and knowledge ...
(Date:2/7/2016)... (PRWEB) , ... February 07, 2016 , ... Women's Excellence ... National Wear Red Day. National Wear Red Day is the first Friday each ... Heart disease and stroke cause 1 in 3 deaths among women each year – ...
(Date:2/7/2016)... AZ (PRWEB) , ... February 07, 2016 , ... ... Neck and Facial Plastics, has added Kybella® to his medical and surgical expertise. ... a newly approved FDA injectable medication used as a non-surgical alternative for reduction ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... India , February 8, 2016 ... a new market research report "Ablation Technologies Market by ... (Csardiovascular, Cancer, Pain Management, Cosmetic Surgery, Ophthalmology, Gynecology) - ... studies the global market over the forecast period of ... $4.44 Billion by 2020, at CAGR of 10.5% from ...
(Date:2/8/2016)... Kan. , Feb. 8, 2016 /PRNewswire/ ... organization that formerly specialized in the development ... recently announced that it has divided its ... Capital. While Nueterra Capital will continue the ... services, NueHealth will operate a national system ...
(Date:2/8/2016)... , Feb. 8, 2016  A research team ... scientists has discovered details of how the abnormal breakage ... a particularly aggressive form of acute lymphoblastic leukemia (ALL). ... which genetic mutations trigger overproduction of immature cells, called ... The discoveries of the malfunction underlying the type called ...
Breaking Medicine Technology: